Clinical trial
Clozapine IM and Aggression in Schizophrenic Patients
NCT00189995 · Beersheva Mental Health Center, Other · Withdrawn
Key facts
| NCT number | NCT00189995 |
|---|---|
| Title | Clozapine IM and Aggression in Schizophrenic Patients |
| Official title | Intramuscular Clozapine in the Management of Aggression in Schizophrenic Patients |
| Lead sponsor | Beersheva Mental Health Center, Other |
| Status | Withdrawn |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Schizophrenia |
| Intervention type | Drug |
| Interventions | clozapine, haloperidol |
| Enrollment | 0 |
| First posted | Sep 19, 2005 |
| Last update posted | Jul 24, 2013 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: